Keeping your research data freely available is crucial for open science — and your funding could depend on it.

New head of Science Europe says he hopes for experiments with grant lottery system and even a basic income for researchers.

Public regard for scientists is as strong as ever, but you wouldn't know it. Public trust in scientists has risen over the past three decades in the United Kingdom, even in the post-Brexit era.

Customers question whether paid articles in digital magazines are worth the money.

A flawed article claiming that manuscripts don't change much between being preprints and published articles somehow makes it through peer review unchanged.

A free and open way to track the online buzz around scholarly articles, by Jason Priem.

Women shouldn't have to shoulder the burden of solving gender inequality on social media: by visibly contradicting stereotypes about female scientists, it is clear that they hope to inspire girls to pursue science and to encourage female scientists to showcase their femininity in our male-dominated workspaces.

A series of talks on robust research practices in psychology and the biomedical sciences, held in Oxford in 2017. Organized by Dorothy Bishop, Ana Todorovic, Caroline Nettekoven and Verena Heise.

Researchers can submit their work directly from bioRxiv to F1000Research offering more choice and flexibility to authors in deciding when to set preprints to under invited peer review.

After Jeffrey Beall took down his list of predatory journals in January 2017 in order to avoid continued harassment and threats, a small group of scholars and information professionals decided to anonymously rebuild and resurrect that list.

Following the shutdown of Beall’s list, blacklists that warn against questionable publishers are in demand.

A short list of common issues that can delay a submission. Check your manuscript for these issues, and and then read our advice for how to fix them.

Researcher-centric communication, collaboration and attribution platform powered by blockchain - with proof-of-existence and real-time, permanent, citing for all scientific and scholarly works.

The drug albuterol can provide fast-acting relief to the wheezing and shortness of breath that often accompany an asthma attack but it often fails minority children.